Grifols SA (GRFS)
7.985
-0.02
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
7.985
0.00 (0.00%)
After-Hours: 20:00
Grifols Shareholders Equity (Quarterly) : 6.341B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.341B |
| March 31, 2026 | 6.289B |
| December 31, 2025 | 6.191B |
| September 30, 2025 | 6.085B |
| June 30, 2025 | 6.068B |
| March 31, 2025 | 6.092B |
| December 31, 2024 | 6.093B |
| September 30, 2024 | 5.971B |
| June 30, 2024 | 5.994B |
| March 31, 2024 | 6.419B |
| December 31, 2023 | 5.930B |
| September 30, 2023 | 6.487B |
| June 30, 2023 | 6.395B |
| March 31, 2023 | 6.359B |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 6.374B |
| December 31, 2020 | 6.250B |
| September 30, 2020 | 6.270B |
| June 30, 2020 | 6.026B |
| Date | Value |
|---|---|
| March 31, 2020 | 6.083B |
| December 31, 2019 | 5.413B |
| September 30, 2019 | 5.202B |
| June 30, 2019 | 5.004B |
| March 31, 2019 | 4.942B |
| December 31, 2018 | 4.830B |
| September 30, 2018 | 4.814B |
| June 30, 2018 | 4.632B |
| March 31, 2018 | 4.557B |
| December 31, 2017 | 4.358B |
| September 30, 2017 | 4.235B |
| June 30, 2017 | 4.082B |
| March 31, 2017 | 4.075B |
| December 31, 2016 | 3.925B |
| September 30, 2016 | 3.965B |
| June 30, 2016 | 3.786B |
| March 31, 2016 | 3.752B |
| December 31, 2015 | 3.581B |
| September 30, 2015 | 3.570B |
| June 30, 2015 | 3.421B |
| March 31, 2015 | 3.363B |
| December 31, 2014 | 3.216B |
| September 30, 2014 | 3.201B |
| June 30, 2014 | 3.055B |
| March 31, 2014 | 3.059B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 74.84M |
| argenx SE | -- |
| Evaxion AS | 9.531M |
| Akari Therapeutics Plc | 18.60M |
| Pharma Mar SA | 286.71M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.97B |
| Total Liabilities (Quarterly) | 13.83B |
| Debt to Equity Ratio | 1.536 |
| Current Ratio | 2.372 |
| Net Debt Paydown Yield | 12.20% |